Clinical Trial Update: A Novel Approach for Reducing Hyperoxaluria and Kidney Stone Risk. [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports completion of a study evaluating a novel approach to reduce hyperoxaluria and lower kidney stone risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperoxaluria

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Hyperoxaluria | Phase 4 | Status: COMPLETED